Search Results

NOVARTIS: RADICALLY REMAKING ITS DRUG BUSINESS.

• Authors : Capell, Kerry

Subjects: PHARMACEUTICAL industry management; FINANCE of pharmaceutical research; RESEARCH managementNOVARTIS AGVASELLA, Daniel L.

• Source: BusinessWeek; 6/22/2009, Issue 4136, p030-035, 6p

Record details

THE DRUG MERGERS' HARSH SIDE EFFECTS.

• Authors : Arnst, Catherine

Subjects: PHARMACEUTICAL industry mergers; RESEARCH & development; FINANCE of pharmaceutical research

• Source: BusinessWeek; 3/23/2009, Issue 4124, p26-26, 1p

Record details

Lilly's Risky Rush Into Cancer Drugs.

• Authors : Arnst, Catherine; Capell, Kerry

Subjects: PHARMACEUTICAL industry & economics; FINANCE of pharmaceutical research; CANCER researchELI Lilly & Co.; IMCLONE Systems Inc.; F. Hoffmann-La Roche Ltd.

• Source: BusinessWeek; 10/20/2008, Issue 4104, p072-072, 1p, 1 Color Photograph

Record details

Drug Research.

Subjects: FINANCE of pharmaceutical researchUNITED States

• Source: BusinessWeek; 12/23/1944, Issue 799, p68-68, 1/3p

Record details